144 related articles for article (PubMed ID: 11975851)
1. Adenovirally transduced dendritic cells induce bispecific cytotoxic T lymphocyte responses against adenovirus and cytomegalovirus pp65 or against adenovirus and Epstein-Barr virus EBNA3C protein: a novel approach for immunotherapy.
Hamel Y; Blake N; Gabrielsson S; Haigh T; Jooss K; Martinache C; Caillat-Zucman S; Rickinson AB; Hacein-Bey S; Fischer A; Cavazzana-Calvo M
Hum Gene Ther; 2002 May; 13(7):855-66. PubMed ID: 11975851
[TBL] [Abstract][Full Text] [Related]
2. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens.
Karlsson H; Brewin J; Kinnon C; Veys P; Amrolia PJ
J Immunother; 2007; 30(5):544-56. PubMed ID: 17589295
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.
Keever-Taylor CA; Margolis D; Konings S; Sandford GR; Nicolette CA; Lawendowski C; Burns WH
Biol Blood Marrow Transplant; 2001; 7(5):247-56. PubMed ID: 11400946
[TBL] [Abstract][Full Text] [Related]
4. A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants.
Lucas KG; Sun Q; Burton RL; Tilden A; Vaughan WP; Carabasi M; Salzman D; Ship A
Hum Gene Ther; 2000 Jul; 11(10):1453-63. PubMed ID: 10910142
[TBL] [Abstract][Full Text] [Related]
5. Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation.
Hanley PJ; Shaffer DR; Cruz CR; Ku S; Tzou B; Liu H; Demmler-Harrison G; Heslop HE; Rooney CM; Gottschalk S; Bollard CM
Cytotherapy; 2011 Sep; 13(8):976-86. PubMed ID: 21539497
[TBL] [Abstract][Full Text] [Related]
6. Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells.
Forsberg O; Carlsson B; Tötterman TH; Essand M
Br J Haematol; 2008 Apr; 141(2):188-99. PubMed ID: 18307565
[TBL] [Abstract][Full Text] [Related]
7. Induction of T-cell immunity against Epstein-Barr virus-associated tumors by means of adenovirally transduced dendritic cells.
Sun H; Yao K; Chen Y; Zhou F
Chin Med J (Engl); 2004 Oct; 117(10):1558-63. PubMed ID: 15498383
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous ex vivo expansion of cytomegalovirus and Epstein-Barr virus-specific cytotoxic T lymphocytes using B-lymphoblastoid cell lines expressing cytomegalovirus pp65.
Sun Q; Pollok KE; Burton RL; Dai LJ; Britt W; Emanuel DJ; Lucas KG
Blood; 1999 Nov; 94(9):3242-50. PubMed ID: 10556213
[TBL] [Abstract][Full Text] [Related]
9. Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies.
Gottschalk S; Edwards OL; Sili U; Huls MH; Goltsova T; Davis AR; Heslop HE; Rooney CM
Blood; 2003 Mar; 101(5):1905-12. PubMed ID: 12411306
[TBL] [Abstract][Full Text] [Related]
10. Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.
Heine A; Grünebach F; Holderried T; Appel S; Weck MM; Dörfel D; Sinzger C; Brossart P
Mol Ther; 2006 Feb; 13(2):280-8. PubMed ID: 16219490
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo stimulation of cytomegalovirus (CMV)-specific T cells using CMV pp65-modified dendritic cells as stimulators.
Carlsson B; Cheng WS; Tötterman TH; Essand M
Br J Haematol; 2003 May; 121(3):428-38. PubMed ID: 12716365
[TBL] [Abstract][Full Text] [Related]
12. Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus.
Solache A; Morgan CL; Dodi AI; Morte C; Scott I; Baboonian C; Zal B; Goldman J; Grundy JE; Madrigal JA
J Immunol; 1999 Nov; 163(10):5512-8. PubMed ID: 10553078
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous generation of cytomegalovirus-specific CD8+ and CD4+ T lymphocytes by use of dendritic cells comodified with pp65 mRNA and pp65 protein.
Carlsson B; Hou M; Giandomenico V; Nilsson B; Totterman TH; Essand M
J Infect Dis; 2005 Dec; 192(11):1912-20. PubMed ID: 16267762
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous generation of multivirus-specific and regulatory T cells for adoptive immunotherapy.
Lugthart G; Albon SJ; Ricciardelli I; Kester MG; Meij P; Lankester AC; Amrolia PJ
J Immunother; 2012 Jan; 35(1):42-53. PubMed ID: 22130159
[TBL] [Abstract][Full Text] [Related]
15. Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus--positive Hodgkin's lymphoma.
Gahn B; Siller-Lopez F; Pirooz AD; Yvon E; Gottschalk S; Longnecker R; Brenner MK; Heslop HE; Aguilar-Cordova E; Rooney CM
Int J Cancer; 2001 Sep; 93(5):706-13. PubMed ID: 11477583
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination.
Ranieri E; Herr W; Gambotto A; Olson W; Rowe D; Robbins PD; Kierstead LS; Watkins SC; Gesualdo L; Storkus WJ
J Virol; 1999 Dec; 73(12):10416-25. PubMed ID: 10559360
[TBL] [Abstract][Full Text] [Related]
17. [CMV pp65 gene modified dendritic cells activate autologous T cells].
Gao GX; Chen XQ; Zhang JY; Zhu HF; Dong BX; Gu HT; Gao Y; Pan YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):397-400. PubMed ID: 18426673
[TBL] [Abstract][Full Text] [Related]
18. Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers.
Szmania S; Galloway A; Bruorton M; Musk P; Aubert G; Arthur A; Pyle H; Hensel N; Ta N; Lamb L; Dodi T; Madrigal A; Barrett J; Henslee-Downey J; van Rhee F
Blood; 2001 Aug; 98(3):505-12. PubMed ID: 11468143
[TBL] [Abstract][Full Text] [Related]
19. Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.
Nair SK; De Leon G; Boczkowski D; Schmittling R; Xie W; Staats J; Liu R; Johnson LA; Weinhold K; Archer GE; Sampson JH; Mitchell DA
Clin Cancer Res; 2014 May; 20(10):2684-94. PubMed ID: 24658154
[TBL] [Abstract][Full Text] [Related]
20. Characterization of antigen-specific repertoire diversity following in vitro restimulation by a recombinant adenovirus expressing human cytomegalovirus pp65.
Hamel Y; Rohrlich P; Baron V; Bonhomme D; Rieux-Laucat F; Necker A; Lemonnier F; Ferradini L; Fischer A; Cavazzana-Calvo M
Eur J Immunol; 2003 Mar; 33(3):760-8. PubMed ID: 12616496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
